Summit Therapeutics (SMMT) Price to Sales (2017 - 2022)
Powered by 
Analysis
Summit Therapeutics (SMMT) Price to Sales (2017 - 2022) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Summit Therapeutics | 13.67 Bn | 12.98 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2022 | 803.70 |
| Jun 30, 2022 | 417.54 |
| Mar 31, 2022 | 961.60 |
| Dec 31, 2021 | 1,050.70 |
| Sep 30, 2021 | 373.66 |
| Jun 30, 2021 | 12,741.13 |
| Mar 31, 2021 | 2,535.09 |
| Dec 31, 2020 | 2,097.85 |
| Sep 30, 2020 | 1,277.78 |
| Jun 30, 2020 | 1,174.58 |
| Mar 31, 2020 | 491.79 |
| Dec 31, 2019 | 486.35 |
| Oct 31, 2019 | 345.10 |
| Sep 30, 2019 | 388.22 |
| Jul 31, 2019 | 141.63 |
| Mar 31, 2019 | 64.25 |
| Oct 31, 2018 | 142.67 |
| Jul 31, 2018 | 3.34 |
| Apr 30, 2018 | 176.52 |
| Jan 31, 2018 | 230.75 |